Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-Co...
Uložené v:
| Vydané v: | Emerging infectious diseases Ročník 26; číslo 8; s. 1944 - 1946 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
U.S. National Center for Infectious Diseases
01.08.2020
Centers for Disease Control and Prevention |
| Predmet: | |
| ISSN: | 1080-6040, 1080-6059, 1080-6059 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-CoV-2 detection were contaminated with synthetic control material, causing delays of regional testing roll-out in various countries. |
|---|---|
| Bibliografia: | SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 PMCID: PMC7392437 |
| ISSN: | 1080-6040 1080-6059 1080-6059 |
| DOI: | 10.3201/eid2608.201843 |